LOS ANGELES, July 24, 2023 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises ImmunityBio, Inc. (“ImmunityBio” or the “Company”) IBRX investors that a lawsuit filed on behalf of investors that purchased ImmunityBio securities between May 23, 2022 and May 10, 2023, both dates inclusive (the “Class Period”). Investors are encouraged…Read More
ImmunityBio investorsPlease contact the Portnoy Law Firm to recover your losses August 29 2023 deadline ImmunityBio NASDAQIBRX
